We intend to capitalize on the ability of our management team to identify, acquire and operate a business or businesses that can benefit from our management team’s established global relationships and operating experience. We believe the digital media, sports, entertainment, leisure and gaming industries possess attractive potential business combination targets that have ample opportunity for […]

We intend to focus our search for a target business in the broadly defined energy transition or sustainability arena. Specifically, we plan to concentrate our search on supply-side solutions and innovations that enable the economy to decarbonize in sectors that include renewable fuels, sustainable chemical production and feedstocks, carbon capture, utilization and storage technology and equipment, […]

(Note: This is a SPAC or blank-check IPO of 12.5 million Class A ordinary shares  – NOT units.)  We intend to focus on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, […]

It is our intention to pursue prospective targets that are focused on health care and biopharma. Sarissa will target businesses with valuations of $500 million to $1 billion that have the potential to be substantially greater over time due to their underlying business characteristics and growth opportunities as a public company. Our focus will be on the health-care industry […]

Supernova Partners Acquisition Company, Inc., a newly formed blank check company, was established by Spencer Rascoff, Alexander Klabin, Robert Reid and Michael Clifton to leverage their extensive experience in acquiring, building, operating and scaling businesses in constantly evolving environments. We intend to partner with an advantaged growth company that benefits from thematic shifts and tech-enabled […]

We intend to focus our search on the financial technology sector, which complements the expertise of our management team. We currently intend to concentrate our efforts identifying businesses in the financial services industry with an enterprise value of approximately $600 million to $1.3 billion, with particular emphasis on businesses that are providing or changing technology for […]

We intend to capitalize on our management team’s background to identify and acquire a business in the life sciences industry. In particular, we will target companies in the biotechnology sector where our management team has extensive experience with a focus on identifying target businesses in developed countries including, but not limited to, the United States […]

We intend to concentrate our efforts in identifying businesses in the media and entertainment industries, with a focus on differentiated product and service offerings. In particular, we expect to seek assets that target three broad themes: (1) innovative platforms that support evolving consumer trends; (2) next-generation technology that may unlock new markets and strong growth; and (3) traditional […]

The chromatin regulatory system orchestrates gene expression–the turning on and off of genes–which is fundamental to how all our cells function. Breakdowns in this system lead to a wide range of diseases impacting millions of patients. Understanding the mechanism of how this system works could lead to an entirely new class of therapeutics. To our […]

We intend to focus on businesses primarily operating in the health care and health care provider space in North America and Asia-Pacific. Possible targets may include hospitals or hospital networks, specialty clinics chains, chronic disease health care service providers, telemedicine/digital health providers and/or associated technology/platform enablers, or artificial intelligence/big data enabled diagnostic providers.  We believe the […]